PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 1982BMJ1,694 citationsOpen Access

Two-, six-, and 12-minute walking tests in respiratory disease.

RBR. J. A. ButlandJPJ. A. PangEGE R Gross

Key Points

  • To evaluate the effectiveness of walking tests in monitoring respiratory disease outcomes.
  • Conducted walking tests at two, six, and twelve minutes in patients with respiratory diseases.
  • Monitored clinical relapses and treatment responses, particularly to vancomycin.
  • Analyzed stool samples for the presence of C difficile and cytotoxin.
  • Patients exhibited clinical improvements corresponding with vancomycin treatment, controlling diarrhea.
  • Stool samples remained negative for C difficile and its cytotoxin over 10 weeks
  • No adverse reactions to vancomycin were reported throughout the treatment.

Abstract

Over the ensuing seven months she had three more clinical relapses, each accompanied by reappearance in the stools of either the organism or its cytotoxin, or both. Each improvement after vancomycin (eight to 14-day- courses) was accompanied by disappearance of the organism. At one point she was given cholestyramine, but she was unable to tolerate it. Her illness was punctuated by malnutrition and episodes of heart failure. She was given no other antibiotics. After the sixth relapse maintenance treatment with oral vancomycin 125 mg eight-hourly was begun. With this regimen diarrhoea was controlled and stools over the next 10 weeks remained negative for C difficile and its cytotoxin. There was no adverse reaction to vancomycin throughout.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Butland et al. (1982) studied this question.

synapsesocial.com/papers/69d851258cb8f39931ae2eaehttps://doi.org/10.1136/bmj.284.6329.1607
Ask AI
Helpful
Bookmark
Share
View Full Paper